How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy
More barriers separate doctors and patients than ever before, from rising costs and time constraints to electronic health records and smartphones.
As part of the acquisition, 160 AccentHealth employees will join ContextMedia, which has a staff of about 500 people.
Drugmakers can do a better job of organizing dosing information, safety information, and clinical data on their brand websites, a new survey found.
The AMA votes in favor of value-based drug pricing; Amgen says insurers are balking at PCSK9 inhibitor prices; docs aren't focused on prices when prescribing
Insurers and pharmacy benefit managers already have a sophisticated understanding of clinical data, the industry argued.
How pharma distributes information to doctors is changing as rapidly as how doctors prefer to receive and process such information
It's becoming less and less likely that an in-person physician/sales rep interaction will take place at the healthcare provider's office.
The partnership allows Sermo to expand the reach of its research initiatives and Everyday Health to scale its targeted advertising on the social platform.
Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines
For some people in the industry ecosystem, the appeal of promo knickknacks endures.
Rising healthcare costs, the need for team health delivery and enhanced teamwork, and empowered consumers have all played a role.
Patients who ask for a prescription after seeing an ad are more likely to get one; Mylan's executive pay is now under scrutiny
Drugmakers routinely pay ghostwriters to write industry-funded research articles; Horizon to buy Raptor for $800 million; WellDoc partners with J&J
Physicians are seeking beyond-the-pill services from drugmakers, but few sales reps shares details with docs about these programs, a new report finds.
The intersection of data, technology, and medicine is rapidly changing how doctors practice, drug companies market, and patients engage with the healthcare system.
The availability of online medical information is changing the way doctors share and receive information — both among themselves and with their patients.
Another study finds doctors who receive gifts from drugmakers prescribe their drugs; Part D spending rose 17% in 2014; Mallinckrodt to open New Jersey site
The event technology platform plans to integrate a conference note-taking app developed by AstraZeneca and DigitasLBi.
Many patients find it difficult to ask questions of their physician.
A new analysis suggests that $20 industry-sponsored meals may sway docs' prescribing habits.
Physicians debate DTC tax write-off; Novo Nordisk's Victoza shows 13% benefit in reducing cardiovascular risks; Shire to acquire Pfizer bowel drug
In partnership with inVentiv Health, MM&M found a millennial doctor to ask about her frustrations with the existing pharma marketing model to her willingness to text patients.
Drugmakers like Merck are making a big education push as they lay the groundwork for future biosimilars.
A Sermo poll asked physicians: Do you feel biosimilars will prove safe and effective enough for you to prescribe them when more become available?"
Online doctors prescribe drugs without adequate warnings; House lawmakers to discuss Part B proposal; obesity drugs struggle for market share
DTC is facing a new test from physicians and politicians. Here's why critics fear a deluge, and how they're pushing back.
The American College of Physicians questioned the role direct-to-consumer advertising plays in contributing to prescription drug costs.
The motivating force behind My GI Health met initial resistance. After all, it came from a company executive who professed that his goal was to benefit all companies within that therapeutic area.
Tom McCourt says he's "a marketing guy who hopefully understands a little about drug development" even as he guided drugs like Prilosec to market.
- The 2017 pipeline report: What to know about next year's launches
- Five things for pharma marketers to know: Monday, November 28, 2016
- Lilly's branded app for Trulicity looks to address adherence
- Lawmakers cut CME exemption from 21st Century Cures Act
- Five things for pharma marketers to know: Tuesday, November 29, 2016
- Boehringer Ingelheim launches gamified support program
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- Five things for pharma marketers to know: Monday, December 5, 2016
- Prescription drug spending rises 9% in 2015, to $324 billion
- As users move to mobile, Google says they made 200 million queries for info about cancer drugs
- Five things for pharma marketers to know: Friday, December 2, 2016
- Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.